STAT3 and Sepsis: α7 nAChR agonists control systemic inflammation in sepsis by inhibiting the JAK2/STAT3 pathway which plays an important role in transducing a multitude of inflammatory signals; it has been considered as a therapeutic target for suppressing inflammatory process [28]–[30].